In addition, they showed that the use of sitagliptin helped down-regulate retinol-binding protein-4 (RBP-4), a molecule that is known to be positively correlated with the severity of glucose intolerance and insulin resistance in women with previous GDM. This evidence concerns the gene RBP4 and gestational diabetes.